Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz.
暂无分享,去创建一个
M. Kazatchkine | F. Clavel | G. Peytavin | L. Bélec | L. Weiss | C. Piketty | A. Si‐Mohamed | P. Castiel | G. González-Canali | E. Race